Blackstone Life Sciences and Anthos Therapeutics, Inc., a transformative, clinical-stage biopharmaceutical company developing innovative therapies for the treatment of cardiometabolic diseases, announced that Novartis...
Riyadh, KSA – WEBWIRE – Tuesday, February 18, 2025
Bader Al-Kharafi: “Focus on operational efficiency, digital innovation, new business verticals and expansion of 5G services...
Blackstone Life Sciences and Anthos Therapeutics, Inc. (“Anthos” or the “company”), a transformative, clinical-stage biopharmaceutical company developing innovative therapies for the treatment of...